Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (21)
Lu Chen, Huanying Shi, WenXin Zhang, Yongjun Zhu, Haifei Chen, Zimei Wu, Huijie Qi, Jiafeng Liu, Mingkang Zhong, Xiaojin Shi, Tianxiao Wang & Qunyi Li. (2024) Carfilzomib suppressed LDHA-mediated metabolic reprogramming by targeting ATF3 in esophageal squamous cell carcinoma. Biochemical Pharmacology 219, pages 115939.
Crossref
Crossref
Benjamin Motais, Sandra Charvátová, Zuzana Walek, Roman Hájek & Juli R. Bagó. (2023) NK92 Expressing Anti-BCMA CAR and Secreted TRAIL for the Treatment of Multiple Myeloma: Preliminary In Vitro Assessment. Cells 12:23, pages 2748.
Crossref
Crossref
Tingting Zheng, Panpan Chen, Yuanlin Xu, Peijun Jia, Yan Li, Yating Li, Jiaming Cao, Wanxin Li, Yazhe Zhen, Ying Zhang, Shijie Zhang, Jiangfeng Du & Jingxin Zhang. (2023) Comprehensive analysis of thirteen-gene panel with prognosis value in Multiple Myeloma. Cancer Biomarkers, pages 1-11.
Crossref
Crossref
Jack G. Fisher, Amber D. P. Doyle, Lara V. Graham, Shreyanshi Sonar, Ben Sale, Isla Henderson, Luis Del Rio, Peter W. M. Johnson, Yosef Landesman, Mark S. Cragg, Francesco Forconi, Christopher J. Walker, Salim. I. Khakoo & Matthew D. Blunt. (2023) XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression. Leukemia.
Crossref
Crossref
Sandra Charvátová, Benjamin Motais, Justyna Czapla, Tomasz Cichoń, Ryszard Smolarczyk, Zuzana Walek, Sebastian Giebel, Roman Hájek & Juli R. Bagó. (2023) Novel Local “Off-the-Shelf” Immunotherapy for the Treatment of Myeloma Bone Disease. Cells 12:3, pages 448.
Crossref
Crossref
Jack Fisher, Amber Doyle, Lara Graham, Salim Khakoo & Matthew Blunt. (2022) Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer. Vaccines 10:12, pages 1993.
Crossref
Crossref
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, Laura Córdoba, Elena Maroto-Martín, Jessica Encinas, Alejandra Leivas, Paula Río & Joaquín Martínez-López. (2022) Overcoming tumor resistance mechanisms in CAR-NK cell therapy. Frontiers in Immunology 13.
Crossref
Crossref
Joseph Andrew Clara, Emily R Levy, Robert Reger, Stefan Barisic, Long Chen, Elena Cherkasova, Mala Chakraborty, David S J Allan & Richard Childs. (2022) High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells. Journal for ImmunoTherapy of Cancer 10:2, pages e003804.
Crossref
Crossref
Joseph A. Clara & Richard W. Childs. (2022) Harnessing natural killer cells for the treatment of multiple myeloma. Seminars in Oncology 49:1, pages 69-85.
Crossref
Crossref
Jack G. Fisher, Christopher J. Walker, Amber DP. Doyle, Peter WM. Johnson, Francesco Forconi, Mark S. Cragg, Yosef Landesman, Salim. I. Khakoo & Matthew D. Blunt. (2021) Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E. Frontiers in Oncology 11.
Crossref
Crossref
Masaki Ri, Shinsuke Iida, Dai Maruyama, Aya Sakabe, Ryo Kamei, Takuto Nakashima, Masahiro Tohkin, Satoshi Osaga, Kensei Tobinai, Noriko Fukuhara, Kana Miyazaki, Norifumi Tsukamoto, Hideki Tsujimura, Makoto Yoshimitsu, Kenichi Miyamoto, Kunihiro Tsukasaki & Hirokazu Nagai. (2021) HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1). Cancer Science 112:12, pages 5011-5019.
Crossref
Crossref
Ehsan Razeghian, Wanich Suksatan, Heshu Sulaiman Rahman, Dmitry O. Bokov, Walid Kamal Abdelbasset, Ali Hassanzadeh, Faroogh Marofi, Mahboubeh Yazdanifar & Mostafa Jarahian. (2021) Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges. Frontiers in Immunology 12.
Crossref
Crossref
Jaya Lakshmi Thangaraj, Seo-Yeon Ahn, Sung-Hoon Jung, Manh-Cuong Vo, Tan-Huy Chu, Minh-Trang Thi Phan, Minsuk Kwon, Kyung-Hwa Lee, Mihee Kim, Ga-Young Song, Deok-Hwan Yang, Jae-Sook Ahn, Hyeoung-Joon Kim, Duck Cho & Je-Jung Lee. (2021) Expanded natural killer cells augment the antimyeloma effect of daratumumab, bortezomib, and dexamethasone in a mouse model. Cellular & Molecular Immunology 18:7, pages 1652-1661.
Crossref
Crossref
Chiara Boccellato, Emily Kolbe, Nathalie Peters, Viktorija Juric, Gavin Fullstone, Maïté Verreault, Ahmed Idbaih, Martine L. M. Lamfers, Brona M. Murphy & Markus Rehm. (2021) Marizomib sensitizes primary glioma cells to apoptosis induced by a latest-generation TRAIL receptor agonist. Cell Death & Disease 12:7.
Crossref
Crossref
Ying Yang, Zhuogang Liu, Hongtao Wang & Guojun Zhang. (2021) HLA-E Binding Peptide as a Potential Therapeutic Candidate for High-Risk Multiple Myeloma. Frontiers in Oncology 11.
Crossref
Crossref
David S.J. Allan, Mala Chakraborty, Giacomo C. Waller, Michael J. Hochman, Akkapon Poolcharoen, Robert N. Reger & Richard W. Childs. (2021) Systematic improvements in lentiviral transduction of primary human natural killer cells undergoing ex vivo expansion. Molecular Therapy - Methods & Clinical Development 20, pages 559-571.
Crossref
Crossref
Varun Vijay Prabhu, Sara Morrow, Abed Rahman Kawakibi, Lanlan Zhou, Marie Ralff, Jocelyn Ray, Aakash Jhaveri, Isacco Ferrarini, Young Lee, Cassandra Parker, Yiqun Zhang, Robyn Borsuk, Wen-I Chang, Joshua N. Honeyman, Fabio Tavora, Benedito Carneiro, Alexander Raufi, Kelsey Huntington, Lindsey Carlsen, Anna Louie, Howard Safran, Attila A. Seyhan, Rohinton S. Tarapore, Lee Schalop, Martin Stogniew, Joshua E. Allen, Wolfgang Oster & Wafik S. El-Deiry. (2020) ONC201 and imipridones: Anti-cancer compounds with clinical efficacy. Neoplasia 22:12, pages 725-744.
Crossref
Crossref
Zhao-Jun Li, Ya-Jun Hou, Gang-Ping Hao, Xiao-Xuan Pan, Hong-Rong Fei & Feng-Ze Wang. (2020) CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells. Journal of Cell Communication and Signaling 14:4, pages 377-387.
Crossref
Crossref
Hua Bai, Yudi Zhu, Peipei Xu & Bing Chen. (2020) PLP2 Expression as a Prognostic and Therapeutic Indicator in High-Risk Multiple Myeloma. BioMed Research International 2020, pages 1-8.
Crossref
Crossref
Thomas van Stigt Thans, Janet I. Akko, Annika Niehrs, Wilfredo F. Garcia-Beltran, Laura Richert, Christina M. Stürzel, Christopher T. Ford, Hui Li, Christina Ochsenbauer, John C. Kappes, Beatrice H. Hahn, Frank Kirchhoff, Glòria Martrus, Daniel Sauter, Marcus Altfeld & Angelique Hölzemer. (2019) Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression. Journal of Virology 93:20.
Crossref
Crossref
Andrea Gras Navarro, Heidi Espedal, Justin Joseph, Laura Trachsel-Moncho, Marzieh Bahador, Bjørn Tore Gjertsen, Einar Klæboe Kristoffersen, Anne Simonsen, Hrvoje Miletic, Per Øyvind Enger, Mohummad Rahman & Martha Chekenya. (2019) Pretreatment of Glioblastoma with Bortezomib Potentiates Natural Killer Cell Cytotoxicity through TRAIL/DR5 Mediated Apoptosis and Prolongs Animal Survival. Cancers 11:7, pages 996.
Crossref
Crossref